(2017/05) Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).

(2016/11) Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.

(2015/01) Chondroitin for osteoarthritis.

(2013/03) Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?

(2011/11) Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center.

(2011/06) Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI.

(2010/06) Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration.

(2010/06) Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study

(2009/02) Long-Term Effects of Chondroitins 4 and 6 Sulfate on Knee Osteoarthritis

(2008/09) Potential effects of chondroitin sulfate on joint swelling: a GAIT report.

(2007/01) Symptom and Structure Modifying Properties of Chondroitin Sulfate in Osteoarthritis

(2005/03) Chondroitins 4 and 6 Sulfate in Osteoarthritis of the Knee

(2018/09) Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis.

(2013/06) Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials.

(2012/06) Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties.

(2011/11) Statement on the safety of glucosamine for patients receiving coumarin anticoagulants

(2011/07) Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.

(2011/04) The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature.

(2009/04) Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database

(2011/01) A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals.

(2009/04) Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial.

(2007/03) Current role of glucosamine in the treatment of osteoarthritis. Review

(2006/11) Glucosamine Sulfate Use and Delay of Progression of Knee Osteoarthritis

(2005/01) Glucosamine therapy for treating osteoarthritis

(2003/12) Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate.

(2016/10) Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative.

(2016/01) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.

(2015/11) Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee.

(2013/12) Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis.

(2010/09) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.

(2010/03) The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.

(2010/01) Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis.

(2009/11) The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation.

(2009/01) A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis

(2008/10) The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial.

(2006/02) Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis

(2006/02) Nutritional Supplements for Knee Osteoarthritis - Still No Resolution

(2003/07) Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis.

(2019/06) A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis.

(2012/04) Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain.

(2022/07) Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.

(2021/12) An Investigation into the Effects of a Curcumin Extract (Curcugen ®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.

(2021/06) Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.

(2021/01) Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials.

(2021/01) Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol.

(2020) The Effect of Nanocurcumin in Improvement of Knee Osteoarthritis: A Randomized Clinical Trial.

(2020/08) The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study (Theracurmin).

(2019/07) Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.

(2015/02) Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial.

(2014/11) Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.

(2014/10) Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study (Theracurmin).

(2014/04) Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial.

(2014/03) Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study.

(2012/01) The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial.

(2019/08) Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.

(2015/06) Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).

(2013/05) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

(2010/09) Folate supplementation during methotrexate therapy for rheumatoid arthritis.

(2009/03) Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.

(2009/01) Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.

(2004/12) Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.

(2002/06) Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

(2001/07) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.

(1998/01) The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A meta analysis of randomized controlled trials.

(2022/05) Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.

(2018/02) Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate‐Treated Early Rheumatoid Arthritis Patients.

(2018/01) Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial.

(2018/01) Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis.

(2017/09) Omega-3 Fatty Acids in Rheumatic Diseases: A Critical Review.

(2017/07) Effect of ω-3 polyunsaturated fatty acids on arthritic pain: A systematic review.

(2017/06) Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study.

(2017/04) Clinical Benefits of n-3 PUFA and ɤ-Linolenic Acid in Patients with Rheumatoid Arthritis.

(2017) Polyunsaturated fatty acids: any role in rheumatoid arthritis?

(2015/11) The Effect of Omega-3 Fatty Acids in Patients With Active Rheumatoid Arthritis Receiving DMARDs Therapy: Double-Blind Randomized Controlled Trial.

(2015/09) Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis.

(2015/01) Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.

(2012/07) Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis.

(2012/06) Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.

(2006/10) Reduction of Cardiovascular Risk Factors with Longterm Fish Oil Treatment in Early Rheumatoid Arthritis

(2003/01) Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.

(1994/06) Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study.

(1990/06) Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects.

(2022/07) Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.

(2022/04) Effects of curcumin supplementation on metabolic parameters, inflammatory factors and obesity values in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial.

(2012/11) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis.

(2018/01) Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level.

(2017/07) Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study.

(2017/06) Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis.

(2017/06) Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study.

(2017/01) The Role of 25-Hydroxyvitamin D as a Predictor of Clinical and Radiological Outcomes in Early Onset Rheumatoid Arthritis.

(2016/11) Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study.

(2016/09) Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis.

(2016/03) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome.

(2015/08) Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number.

(2015/04) Vitamin D status and its association with quality of life, physical activity, and disease activity in rheumatoid arthritis patients.

(2012/12) Clinical review: Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies.

(2012/10) Vitamin d, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis.

(2011/12) Unsuppressed parathyroid hormone in patients with autoimmune/inflammatory rheumatic diseases: implications for vitamin D supplementation.

(2011/01) Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity.

(2010/09) Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis.

(2022/01) Vitamin D and Marine n-3 Fatty Acid Supplementation and Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial.

(2022/01) Vitamin D and Marine n-3 Fatty Acid Supplementation and Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial.

(2017/05) Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study.

(2013/04) Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia?

(2009/05) Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.

(2002/03) An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome.

(2023/02)Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.

(2021/01)The Effect of a Dispersible Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Joint Pain in an Adult Population – A Randomised, Double-Blind Study.

(2015/12)Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.

(2011/04) Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist.

(2017/12) Effect of vitamin D supplementation in chronic widespread pain: a systematic review and meta-analysis.

(2017/09) The relationship between balance and vitamin 25(OH)D in fibromyalgia patients.

(2017/02) Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial.

(2016/03) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome.

(2015/09) Is Serum Hypovitaminosis D Associated with Chronic Widespread Pain Including Fibromyalgia? A Meta-analysis of Observational Studies.

(2014/02) Effects of vitamin D on patients with fibromyalgia syndrome: A randomized placebo-controlled trial.

(2013/12) Fibromyalgia syndrome: is it related to vitamin D deficiency in premenopausal female patients?

(2019/12) Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review.

(2019) Is there a role for cherries in the management of gout?

(2016/03) Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial.

(2021/08) Association between Oral vitamin C supplementation and serum uric acid: A meta-analysis of randomized controlled trials.

(2011/06) Effect of oral vitamin C supplementation on serum uric acid: A meta‐analysis of randomized controlled trials.

(2010/06) Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.

(2008/08) Dehydroepiandrosterone in systemic lupus erythematosus.

(2008/08) Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.

(2007/10) Dehydroepiandrosterone for systemic lupus erythematosus.

(2005/11) DHEA supplementation: the claims in perspective.

(2004/12) Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.

(2004/11) The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.

(2004/09) Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

(2002/11) Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.

(2002/07) Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

(2002/01) Dehydroepiandrosterone for the treatment of systemic lupus erythematosus.

(2017/11) Omega-3 fatty acids, inflammatory status and biochemical markers of patients with systemic lupus erythematosus: a pilot study.

(2017/09) Omega-3 Fatty Acids in Rheumatic Diseases: A Critical Review.

(2015/08) Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus.

(2015/02) Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus.

(2013/11) Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus.

(2008/06) A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

(2004/08) The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus.

(2023/08) Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density.

(2018/08) The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus.

(2018/07) Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis.

(2017/11) Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): A systematic review.

(2017/09) Effect of vitamin D supplementation on patients with systemic lupus erythematosus: a systematic review.

(2017/08) Serum 25-OH vitamin D level in treatment-naïve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17.

(2017/01) 25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients.

(2012/10) Premature Atherosclerosis Is Associated With Hypovitaminosis D and Angiotensin-Converting Enzyme Inhibitor Non-use in Lupus Patients.

(2012/04) Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.

(2012/04) Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.

(2011/12) Unsuppressed parathyroid hormone in patients with autoimmune/inflammatory rheumatic diseases: implications for vitamin D supplementation.

(2011/09) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus.

(2010/08) Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage.

(2010/06) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

(2010/02) The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.

(2010/01) Vitamin D insufficiency in a large female SLE cohort.

(2009/10) 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus.

(2008/06) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences.